This month's main topic: Preventing 10-Fold Dosage Errors
ISMP Medication Safety Alert!®
Community/Ambulatory
A valuable resource to reduce medication error risk in outpatient settings
The ISMP Medication Safety Alert!®Community/Ambulatory Care is a digital newsletter, published monthly for healthcare practitioners in ambulatory settings, including community pharmacies, outpatient clinics, physician offices, and state institutions.
Who reads this newsletter?
- Community/ambulatory care pharmacists
- Pharmacy managers and executives
- Pharmacy technicians and other pharmacy staff
- Physicians and nurses in ambulatory practice
- Anyone concerned with medication safety
Related
Subscription Options
Online access to twelve (12) issues per year. Subscriptions start with the first issue after the date of purchase. You will receive a reminder notice via email to renew your annual subscription before your subscription expires. Your subscription will not automatically renew.
Access to back issues are not included. Single issues are available for purchase.
Special pricing for group purchase, contact ISMP.
One-year subscription: $65.00
Subscription Information
-
Online access for one (1) user
-
A user log-in required
-
PDF version available to download and redistribute
Browse Issues
Community/Ambulatory
VOLUME 15, ISSUE 8
This month's main topic: ISMP National Vaccine Errors Reporting Program: One in Three Vaccine Errors Associated with Age-Related Factors
Community/Ambulatory
VOLUME 15, ISSUE 7
This month's main topic: QuarterWatch™ Annual Report Issue: Trends and Changes in 2015 that Impact Medication Safety
Community/Ambulatory
VOLUME 15, ISSUE 6
This month's main topic: Tall Man Letters: ISMP Updates its List of Drug Names with Tall Man Letters
Community/Ambulatory
VOLUME 15, ISSUE 5
This month's main topic: Prescribing and Dispensing Errors with Oral Solutions
Community/Ambulatory
VOLUME 15, ISSUE 4
This month's main topic: QuarterWatch™ Latest Edition: Cancer Risks with Biological Products for Psoriasis and Sudden Hearing Loss with Tadalafil and Sildenafil
Community/Ambulatory
VOLUME 15, ISSUE 3
This month's main topic: Do Not Let “Depo-” Medications be a Depot for Mistakes
Community/Ambulatory
VOLUME 15, ISSUE 2
In this month's issue: Government and Industry Fail to Protect the Public when They Suggest “Carefully Following Instructions” is Enough to Prevent Vaccine Errors
Community/Ambulatory
VOLUME 15, ISSUE 1
This month's main topic: QuarterWatch™ 2015 Quarter 1 and 2 Report: Focus on a New Sleep Medication, Changing Opioid Use, and New Diabetes Medications
Community/Ambulatory
VOLUME 14, ISSUE 12
This month's main topic: Dispelling a Few Myths about ISMP
Community/Ambulatory
VOLUME 14, ISSUE 11
This month's main topic: This Holiday Season, Keep Children Safe from Accidental Medication Poisonings
Community/Ambulatory
VOLUME 14, ISSUE 10
This month's main topic: Severe Harm and Death Associated with Medication Errors and Drug-Drug Interactions Involving Low-Dose Methotrexate
Community/Ambulatory
VOLUME 14, ISSUE 9
This month's main topic: QuarterWatch™ 2014 Annual Report: Signals for TNF Blocking Agents, Anticoagulants, Lipitor, Growth Hormone
Community/Ambulatory
Problem: Pharmacists and veterinarians should be aware of the potential for animal injury due to confusion between human drugs and animal drugs that have lookalike or sound-alike names. The US Food and Drug Administration (FDA) Center for Veterinary Medicine (CVM) has recently received a report of a dog mistakenly receiving the human drug SINEQUAN (doxepin) instead of the prescribed animal drug ZENIQUIN (marbofloxacin). The dog became ill (lethargy, anorexia, and oliguria) 24 hours after being administered the SINEquan. Fortunately, the dog was treated and recovered.
Drug name confusions...
Community/Ambulatory
VOLUME 14, ISSUE 8
This month's main topic: Draft Guidelines for the Safe Communication of Electronic Medication Information
Community/Ambulatory
VOLUME 14, ISSUE 7
The month's main topic: Open the Bag to Catch Errors at the Point-of-Sale
Community/Ambulatory
VOLUME 14, ISSUE 6
This month's main topic: One Choice too Many…Time to Eliminate Teaspoonful
Community/Ambulatory
VOLUME 14, ISSUE 5
This month's main topic: QuarterWatch™ 2014 Quarter 2: Zolpidem and Canagliflozin Safety Signals, Thousands of Incomplete Rosiglitazone Reports